Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Oxford Nanopore to participate in upcoming investor conferences

07 January 2026

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in January.

·      44th Annual J.P. Morgan Healthcare Conference, San Francisco

Format: Presentation and Q&A session and investor meetings

Date: Monday, 12 January

Time: 2:15pm PT (5:15pm EST/10:15pm GMT)

Webcast: click here to register

·      dbAccess UK & Ireland Conference, London

Format: One-on-one and group investor meetings

Date: Tuesday, 20 January

A live webcast of the J.P. Morgan presentation and Q&A can be accessed at the Company's investor relations page at: https://nanoporetech.com/about/investors/reports. A webcast replay will be available for at least 30 days following the event via the same link.

-ENDS-

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:        [email protected]

Media:             [email protected]

Teneo (communications adviser to the Company)

Tom Murray, Lisa Jarrett-Kerr

+44 (0) 20 7353 4200

[email protected]

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.  Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com